Equity Overview
Price & Market Data
Price: $18.08
Daily Change: +$0.05 / 0.28%
Range: $17.65 - $18.43
Market Cap: $195,403,216
Volume: 38,252
Performance Metrics
1 Week: 5.73%
1 Month: 9.38%
3 Months: -8.83%
6 Months: 5.06%
1 Year: 10.18%
YTD: 1.57%
Company Details
Employees: 111
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Israel
Details
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.